Garodia Chemicals Limited Withdraws Record Date for Share Capital Reduction
Garodia Chemicals Limited has withdrawn the record date of March 25, 2026, that was previously set for share capital reduction. The withdrawal was communicated to BSE on April 02, 2026, by Managing Director Ravindra Subhash Salunkhe, in compliance with SEBI listing regulations. The original record date was announced on March 13, 2025, but has now been completely withdrawn.

*this image is generated using AI for illustrative purposes only.
Garodia Chemicals Limited has officially withdrawn the record date previously fixed for the reduction of share capital, as communicated to BSE Limited on April 02, 2026. The company's Managing Director, Ravindra Subhash Salunkhe, signed the formal intimation announcing this corporate action withdrawal.
Record Date Withdrawal Details
The company had initially set March 25, 2026, as the record date for share capital reduction purposes, which was communicated to the stock exchange in an earlier intimation dated March 13, 2025. However, the management has now decided to withdraw this record date entirely.
| Parameter: | Details |
|---|---|
| Original Record Date: | March 25, 2026 |
| Purpose: | Reduction of Share Capital |
| Initial Announcement: | March 13, 2025 |
| Withdrawal Date: | April 02, 2026 |
| BSE Scrip Code: | 530161 |
Regulatory Compliance
The intimation has been made in strict compliance with the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company emphasized that the record date stands completely withdrawn, indicating that the share capital reduction process will not proceed as originally planned.
Management Communication
Managing Director Ravindra Subhash Salunkhe (DIN: 06753149) digitally signed the official communication from Mumbai on April 02, 2026, at 17:38:31 +05'30'. The formal intimation was addressed to BSE Limited's management at Phiroze Jeejeebhoy Tower, Dalal Street, Fort, Mumbai.
The withdrawal represents a significant change in the company's corporate restructuring plans, though no specific reasons for the withdrawal have been disclosed in the official communication to the stock exchange.
What alternative capital restructuring strategies might Garodia Chemicals pursue following this withdrawal?
How will this decision impact the company's debt-to-equity ratio and overall financial leverage going forward?
Could this withdrawal signal potential merger or acquisition discussions that would make share capital reduction unnecessary?

























